These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 30057598)
1. Steatohepatitis Is Not Associated with an Increased Risk for Fibrosis Progression in Nonalcoholic Fatty Liver Disease. Hagström H; Elfwén O; Hultcrantz R; Stål P Gastroenterol Res Pract; 2018; 2018():1942648. PubMed ID: 30057598 [TBL] [Abstract][Full Text] [Related]
2. Natural History of Non-Alcoholic Fatty Liver Disease: A Study With Paired Liver Biopsies. Reddy YK; Marella HK; Jiang Y; Ganguli S; Snell P; Podila PSB; Maliakkal B; Satapathy SK J Clin Exp Hepatol; 2020; 10(3):245-254. PubMed ID: 32405181 [TBL] [Abstract][Full Text] [Related]
3. Association of Histologic Disease Activity With Progression of Nonalcoholic Fatty Liver Disease. Kleiner DE; Brunt EM; Wilson LA; Behling C; Guy C; Contos M; Cummings O; Yeh M; Gill R; Chalasani N; Neuschwander-Tetri BA; Diehl AM; Dasarathy S; Terrault N; Kowdley K; Loomba R; Belt P; Tonascia J; Lavine JE; Sanyal AJ; JAMA Netw Open; 2019 Oct; 2(10):e1912565. PubMed ID: 31584681 [TBL] [Abstract][Full Text] [Related]
4. Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management. McPherson S; Hardy T; Henderson E; Burt AD; Day CP; Anstee QM J Hepatol; 2015 May; 62(5):1148-55. PubMed ID: 25477264 [TBL] [Abstract][Full Text] [Related]
5. Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. Singh S; Allen AM; Wang Z; Prokop LJ; Murad MH; Loomba R Clin Gastroenterol Hepatol; 2015 Apr; 13(4):643-54.e1-9; quiz e39-40. PubMed ID: 24768810 [TBL] [Abstract][Full Text] [Related]
7. LC-MS-based lipidomic analysis in distinguishing patients with nonalcoholic steatohepatitis from nonalcoholic fatty liver. Wang ZH; Zheng KI; Wang XD; Qiao J; Li YY; Zhang L; Zheng MH; Wu J Hepatobiliary Pancreat Dis Int; 2021 Oct; 20(5):452-459. PubMed ID: 34256994 [TBL] [Abstract][Full Text] [Related]
8. Natural History of Simple Steatosis or Nonalcoholic Fatty Liver. De A; Duseja A J Clin Exp Hepatol; 2020; 10(3):255-262. PubMed ID: 32405182 [TBL] [Abstract][Full Text] [Related]
9. Non-invasive Testing for NASH and NASH with Advanced Fibrosis: Are We There Yet? Arulanandan A; Loomba R Curr Hepatol Rep; 2015 Jun; 14(2):109-118. PubMed ID: 26500833 [TBL] [Abstract][Full Text] [Related]
10. A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver. Pais R; Charlotte F; Fedchuk L; Bedossa P; Lebray P; Poynard T; Ratziu V; J Hepatol; 2013 Sep; 59(3):550-6. PubMed ID: 23665288 [TBL] [Abstract][Full Text] [Related]
11. Bioinformatics analysis reveals novel core genes associated with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Feng G; Li XP; Niu CY; Liu ML; Yan QQ; Fan LP; Li Y; Zhang KL; Gao J; Qian MR; He N; Mi M Gene; 2020 Jun; 742():144549. PubMed ID: 32184169 [TBL] [Abstract][Full Text] [Related]
12. IMPACT OF TYPE 2 DIABETES ON NONALCOHOLIC STEATOHEPATITIS AND ADVANCED FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE. Bian H; Zhu X; Xia M; Yan H; Chang X; Hu X; Pan B; Guo W; Li X; Gao X Endocr Pract; 2020 Apr; 26(4):444-453. PubMed ID: 31968197 [No Abstract] [Full Text] [Related]